Casey DE, Karen Collins Faha J, Cheryl Dennison Himmelfarb Mba, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):e127-e248. https://doi.org/10.1016/J.JACC.2017.11.006

Guideline for the Pharmacological Treatment of Hypertension in Adults. World Health Organization; 2021. Accessed January 6, 2023. http://www.ncbi.nlm.nih.gov/books/NBK573631/

Jaffe MG, Frieden TR, Campbell NRC, et al. Recommended Treatment Protocols to Improve Management of Hypertension Globally: a Statement by Resolve to Save Lives and the World Hypertension League (WHL). J Clin Hypertens Greenwich Conn. 2018;20(5):829-836. https://doi.org/10.1111/jch.13280

Article  Google Scholar 

Shah SJ, Stafford RS. Current Trends of Hypertension Treatment in the United States. Am J Hypertens. 2017;30(10):1008-1014. https://doi.org/10.1093/ajh/hpx085

Article  PubMed  PubMed Central  Google Scholar 

An J, Luong T, Qian L, et al. Treatment Patterns and Blood Pressure Control With Initiation of Combination Versus Monotherapy Antihypertensive Regimens. Hypertension. 2021;77(1):103-113. https://doi.org/10.1161/HYPERTENSIONAHA.120.15462

Article  CAS  PubMed  Google Scholar 

Derington CG, King JB, Herrick JS, et al. Trends in Antihypertensive Medication Monotherapy and Combination Use Among US Adults, National Health and Nutrition Examination Survey 2005–2016. Hypertension. Published online 2020:973-981. https://doi.org/10.1161/HYPERTENSIONAHA.119.14360

Wang JG, Kario K, Lau T, et al. Use of Dihydropyridine Calcium Channel Blockers in the Management of Hypertension in Eastern Asians: a Scientific Statement from the Asian Pacific Heart Association. Hypertens Res. 2011;34(4):423-430. https://doi.org/10.1038/hr.2010.259

Article  CAS  PubMed  Google Scholar 

Blood Pressure Lowering Treatment Trialists’ Collaboration. Pharmacological Blood Pressure Lowering for Primary and Secondary Prevention of Cardiovascular Disease Across Different Levels of Blood Pressure: an Individual Participant-Level Data Meta-Analysis. Lancet. 2021;397(10285):1625-1636. https://doi.org/10.1016/S0140-6736(21)00590-0

Article  Google Scholar 

Hayashi K, Wakino S, Sugano N, Ozawa Y, Homma K, Saruta T. Ca2+ Channel Subtypes and Pharmacology in the Kidney. Circ Res. 2007;100(3):342-353. https://doi.org/10.1161/01.RES.0000256155.31133.49

Article  CAS  PubMed  Google Scholar 

Matsushita K, van der Velde M, Astor BC, et al. Association of Estimated Glomerular Filtration Rate and Albuminuria with All-Cause and Cardiovascular Mortality in General Population Cohorts: a Collaborative Meta-Analysis. Lancet. 2010;375(9731):2073-2081. https://doi.org/10.1016/S0140-6736(10)60674-5

Article  PubMed  PubMed Central  Google Scholar 

Gansevoort RT, Matsushita K, Van Der Velde M, et al. Lower Estimated GFR and Higher Albuminuria Are Associated with Adverse Kidney Outcomes. A Collaborative Meta-Analysis of General and High-Risk Population Cohorts. Kidney Int. 2011;80(1):93-104. https://doi.org/10.1038/KI.2010.531

Van Velde MD, Halbesma N, De Charro FT, et al. Screening for Albuminuria Identifies Individuals at Increased Renal Risk. J Am Soc Nephrol. 2009;20(4):852-862. https://doi.org/10.1681/ASN.2008060655

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ishani A, Grandits GA, Grimm RH, et al. Association of Single Measurements of Dipstick Proteinuria, Estimated Glomerular Filtration Rate, and Hematocrit with 25-Year Incidence of End-Stage Renal Disease in the Multiple Risk Factor Intervention Trial. J Am Soc Nephrol. 2006;17(5):1444-1452. https://doi.org/10.1681/ASN.2005091012

Article  CAS  PubMed  Google Scholar 

Griffin KA, Picken MM, Bidani AK. Deleterious Effects of Calcium Channel Blockade on Pressure Transmission and Glomerular Injury in Rat Remnant Kidneys. J Clin Invest. 1995;96(2):793-800. https://doi.org/10.1172/JCI118125

Article  CAS  PubMed  PubMed Central  Google Scholar 

Griffin KA, Bidani AK. Progression of Renal Disease: Renoprotective Specificity of Renin-Angiotensin System Blockade. Clin J Am Soc Nephrol. 2006;1(5):1054-1065. https://doi.org/10.2215/CJN.02231205

Article  PubMed  Google Scholar 

Bakris GL, Weir MR, Secic M, Campbell B, Weis-McNulty A. Differential Effects of Calcium Antagonist Subclasses on Markers of nephropathy Progression. Kidney Int. 2004;65(6):1991-2002. https://doi.org/10.1111/J.1523-1755.2004.00620.X

Article  CAS  PubMed  Google Scholar 

Wright JT, Bakris G, Greene T, et al. Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease: Results From the AASK Trial. JAMA. 2002;288(19):2421-2431. https://doi.org/10.1001/JAMA.288.19.2421

Article  CAS  PubMed  Google Scholar 

Rahman M, Ford CE, Cutler JA, et al. Long-Term Renal and Cardiovascular Outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants by Baseline Estimated GFR. Clin J Am Soc Nephrol. 2012;7(6):989-1002. https://doi.org/10.2215/CJN.07800811

Article  PubMed  PubMed Central  Google Scholar 

Rahman M, Pressel S, Davis BR, et al. Renal Outcomes in High-Risk Hypertensive Patients Treated with an Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Blocker vs a Diuretic: a Report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med. 2005;165(8):936-946. https://doi.org/10.1001/ARCHINTE.165.8.936

Article  CAS  PubMed  Google Scholar 

Furberg CD, Wright JT, Davis BR, et al. Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981-2997. https://doi.org/10.1001/JAMA.288.23.2981

Article  CAS  Google Scholar 

Sumida K, Nadkarni GN, Grams ME, et al. Conversion of Urine Protein–Creatinine Ratio or Urine Dipstick Protein to Urine Albumin–Creatinine Ratio for Use in Chronic Kidney Disease Screening and Prognosis: an Individual Participant–Based Meta-Analysis. Ann Intern Med. 2020;173(6):426-435. https://doi.org/10.7326/M20-0529/SUPPL_FILE/M20-0529_SUPPLEMENT.PDF

Article  PubMed  PubMed Central  Google Scholar 

Inker LA, Eneanya ND, Coresh J, et al. New Creatinine- and Cystatin C-Based Equations to Estimate GFR Without Race. N Engl J Med. 2021;385(19):1737-1749. https://doi.org/10.1056/NEJMOA2102953

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qiao Y, Shin JI, Chen TK, et al. Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate. JAMA Intern Med. 2020;180(5):718-726. https://doi.org/10.1001/jamainternmed.2020.0193

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rubin D. Multiple Imputation for Nonresponse in Surveys. (John Wiley & Sons, ed.).; 2004. https://books.google.com/books?hl=en&lr=&id=bQBtw6rx_mUC&oi=fnd&pg=PR24&ots=8PuF5L6ZhQ&sig=BUDoFYT3Bq6ietIx4aV6xUyOVHI

Jafar TH, Stark PC, Schmid CH, et al. Progression of Chronic Kidney Disease: the Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: a Patient-Level Meta-Analysis. Ann Intern Med. 2003;139(4). https://doi.org/10.7326/0003-4819-139-4-200308190-00006

Article  CAS  PubMed  Google Scholar 

Jafar TH, Schmid CH, Landa M, et al. Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal Disease. A Meta-Analysis of Patient-Level Data. Ann Intern Med. 2001;135(2):73-87. https://doi.org/10.7326/0003-4819-135-2-200107170-00007

Article  CAS  PubMed  Google Scholar 

Hart P, Bakris GL. Calcium Antagonists: Do They Equally Protect Against Kidney Injury? Kidney Int. 2008;73(7):795-796. https://doi.org/10.1038/SJ.KI.5002773

Article  CAS  PubMed  Google Scholar 

Chagnac A, Zingerman B, Rozen-Zvi B, Herman-Edelstein M. Consequences of Glomerular Hyperfiltration: the Role of Physical Forces in the Pathogenesis of Chronic Kidney Disease in Diabetes and Obesity. Nephron. 2019;143(1):38-42. https://doi.org/10.1159/000499486

Article  CAS  PubMed  Google Scholar 

Griffin KA, Picken MM, Bakris GL, Bidani AK. Class Differences in the Effects of Calcium Channel Blockers in the Rat Remnant Kidney Model. Kidney Int. 1999;55(5):1849-1860. https://doi.org/10.1046/J.1523-1755.1999.00434.X

Article  CAS  PubMed  Google Scholar 

Moes AD, Hesselink DA, van den Meiracker AH, Zietse R, Hoorn EJ. Chlorthalidone Versus Amlodipine for Hypertension in Kidney Transplant Recipients Treated With Tacrolimus: a Randomized Crossover Trial. Am J Kidney Dis. 2017;69(6):796-804. https://doi.org/10.1053/J.AJKD.2016.12.017

Article  CAS  PubMed  Google Scholar 

Taal MW, Brenner BM. Renoprotective Benefits of RAS Inhibition: from ACEI to Angiotensin II Antagonists. Kidney Int. 2000;57(5):1803-1817. https://doi.org/10.1046/J.1523-1755.2000.00031.X

Article  CAS  PubMed  Google Scholar 

Fogari R, Preti P, Zoppi A, et al. Effects of Amlodipine Fosinopril Combination on Microalbuminuria in Hypertensive Type 2 Diabetic Patients. Am J Hypertens. 2002;15(12):1042-1049. https://doi.org/10.1016/S0895-7061(02)03017-0

Article  CAS  PubMed  Google Scholar 

Bakris GL, Sarafidis PA, Weir MR, et al. Renal Outcomes with Different Fixed-Dose Combination Therapies in Patients with Hypertension at High Risk for Cardiovascular Events (ACCOMPLISH): a Prespecified Secondary Analysis of a Randomised Controlled Trial. Lancet. 2010;375(9721):1173-1181. https://doi.org/10.1016/S0140-6736(09)62100-0

Article  CAS  PubMed  Google Scholar